• Efficient Transduction of CAR into T-cells
    3D illustration of T cells attacking a cancer cell (CAR-T cell therapy).

Laboratory Products

Efficient Transduction of CAR into T-cells

May 18 2023

AMSBIO introduces a new selection of high-titre Chimeric Antigen Receptor (CAR) lentivirus. This cutting-edge range is specifically designed to deliver exceptional transduction efficiency, enabling efficient and successful incorporation of CAR into both resting and actively dividing T-cells.

The FDA's 2017 approval of CAR-T cells for leukaemia and lymphoma marked a significant milestone in personalised cancer treatment. Since then, the field has experienced rapid expansion, with a surge of research focused on exploring the therapeutic potential of CAR-T cells.

Harnessing the power of CAR-T cell therapies, researchers are increasingly utilising them as a strategic approach to redirect a patient's T-cells, enabling the targeted destruction of specific tumour cells. Among various methods, researchers have discovered that viral vectors exhibit the highest efficacy in transducing CAR into T cells, making them a preferred choice during the CAR-T cell manufacturing process.

AMSBIO's new range of clinical-grade CAR lentivirus presents an ideal solution for ex-vivo generation of CAR-T cells. These lentiviral vectors possess the unique capability to stably integrate large DNA inserts and efficiently transduce both dividing and non-dividing cells. With AMSBIO's CAR lentivirus, researchers gain a powerful tool to facilitate the production of CAR-T cells with enhanced stability and transduction efficiency.

AMSBIO introduces a diverse range of CAR lentivirus products meticulously tailored to accommodate various research applications. Immunotherapy researchers aiming to expedite their timelines can rely on AMSBIO's ready-to-transduce CAR lentivirus, boasting an impressive concentration of up to 10e9 infectious units per millilitre (IFU/ml). With this high-quality resource at their disposal, researchers can efficiently maximise their experimental efficiency and advance their studies in the field of immunotherapy.

More information online

Digital Edition

Lab Asia 31.2 April 2024

April 2024

In This Edition Chromatography Articles - Approaches to troubleshooting an SPE method for the analysis of oligonucleotides (pt i) - High-precision liquid flow processes demand full fluidic c...

View all digital editions



Apr 22 2024 Marrakech, Morroco

Korea Lab 2024

Apr 23 2024 Kintex, South Korea

Korea Chem 2024

Apr 23 2024 Seoul, South Korea

Lab Indonesia

Apr 24 2024 Jakarta, Indonesia

View all events